NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Clinical trials for NEUROMYELITIS OPTICA SPECTRUM DISORDERS explained in plain language.
Never miss a new study
Get alerted when new NEUROMYELITIS OPTICA SPECTRUM DISORDERS trials appear
Sign up with your email to follow new studies for NEUROMYELITIS OPTICA SPECTRUM DISORDERS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New hope for rare nerve disease: stem cell vesicles enter human testing
Disease control Recruiting nowThis early-stage trial tests a new treatment called NouvSoma001 for people with neuromyelitis optica spectrum disorders (NMOSD), a rare disease that attacks the nerves in the eyes and spinal cord. The treatment uses tiny particles from stem cells, given via a spinal injection, to…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: PHASE1 • Sponsor: Tongji Hospital • Aim: Disease control
Last updated May 26, 2026 07:04 UTC
-
New shot aims to stop devastating nerve attacks in rare disease
Disease control Recruiting nowThis study tests an injection called B001 in 132 people with a rare nerve disease called NMOSD. The goal is to see if it can prevent sudden attacks that cause vision loss, weakness, or paralysis. Participants must have had at least one attack in the past year and will be followed…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Jiaolian Drug Research and Development Co., Ltd • Aim: Disease control
Last updated May 22, 2026 13:53 UTC
-
Engineered immune cells take aim at Hard-to-Treat autoimmune diseases
Disease control Recruiting nowThis early-phase study tests a new treatment using specially engineered immune cells (CAR T-cells) that target two proteins, CD19 and BCMA, in up to 12 adults with severe autoimmune diseases affecting the brain and nerves, such as multiple sclerosis and myasthenia gravis. The mai…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Phase: EARLY_PHASE1 • Sponsor: Tianjin Huanhu Hospital • Aim: Disease control
Last updated May 20, 2026 11:54 UTC
-
Super MRI scans aim to unlock secrets of brain resilience
Knowledge-focused Recruiting nowThis study uses powerful MRI scanners to look at the brains of 700 people, including those with conditions like multiple sclerosis, Alzheimer's, and Parkinson's, as well as healthy volunteers. The goal is to understand why some brains stay healthy while others develop disease. Re…
Matched conditions: NEUROMYELITIS OPTICA SPECTRUM DISORDERS
Sponsor: Assistance Publique Hopitaux De Marseille • Aim: Knowledge-focused
Last updated May 13, 2026 16:00 UTC